Alpine Immune Sciences Inc (NAS:ALPN)
$ 64.94 0.12 (0.19%) Market Cap: 4.45 Bil Enterprise Value: 4.16 Bil PE Ratio: 0 PB Ratio: 11.95 GF Score: 61/100

Alpine Immune Sciences Inc Investor Event - ASN Kidney Week Transcript

Nov 02, 2023 / 08:30PM GMT
Release Date Price: $14.72 (+39.92%)
Operator

Please standby. Welcome to the Alpine Immune Sciences investor call. Currently, all participants are in a listen-only mode. As a reminder, this event is being recorded. I would now like to introduce Temre Johnson, Senior Director of Investor Relations and Corporate Communications at Alpine. Ms. Johnson please go ahead.

Temre Johnson
Alpine Immune Sciences, Inc. - Senior Director of Investor Relations and Corporate Communications

Thank you, Cynthia. Good afternoon, and thank you to everyone for taking the time to join us today. With me on today's call from Alpine are: Dr. Mitchell Gold, Executive Chairman and Chief Executive Officer; Dr. Stanford Peng, President and Head of Research and Development; Paul Rickey, Chief Financial Officer; and Dr. Remy Durand, Chief Business Officer. Also participating in today's call are: Dr. James Tumlin, Professor from Emory University; and Dr. Jonathan Barratt from the University of Leicester.

Before I turn the call over to Mitch, I'd like to remind you that we'll be making forward-looking statements during today's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot